Ionis Pharmaceuticals Inc/ US4622221004 /
2024-08-28 10:00:00 PM | Chg. +0.9000 | Volume | Bid10:00:10 PM | Ask10:00:10 PM | High | Low |
---|---|---|---|---|---|---|
49.2500USD | +1.86% | 940,035 Turnover: 28.75 mill. |
44.1000Bid Size: 100 | 50.0000Ask Size: 100 | 49.4900 | 47.8625 |
GlobeNewswire
08-13
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Resul...
GlobeNewswire
05-30
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire
05-16
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lat...
GlobeNewswire
05-13
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Result...
GlobeNewswire
05-07
Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
GlobeNewswire
04-23
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held M...
GlobeNewswire
04-22
Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to...
GlobeNewswire
03-06
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...
GlobeNewswire
03-05
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire
02-23
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positiv...
GlobeNewswire
01-08
Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio
GlobeNewswire
2022-03-28
Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotroph...
GlobeNewswire
2022-03-17
Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors
GlobeNewswire
2022-03-14
Biogen Announces New Updates Across its SMA Research Program at 2022 MDA Conference
GlobeNewswire
2022-02-24
ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results
GlobeNewswire
2022-02-02
n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare D...
GlobeNewswire
2022-01-04
Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA
GlobeNewswire
2022-01-03
Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer
GlobeNewswire
2021-12-10
Cytokinetics Announces Data From Its ALS Program Presented at the 32nd International Symposium on AL...
GlobeNewswire
2021-11-15
CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors